The relationship between renal impairment and left ventricular structure, function, and ventricular-arterial interaction in hypertension

Journal of Hypertension

Volumn 29, Issue 9, 2011, Pages 1829-1836

  Shah, Amil M ^a   Lam, Carolyn S P ^b   Cheng, Susan ^a   Verma, Anil ^a   Desai, Akshay S ^a   Rocha, Ricardo A ^c   Hilkert, Robert ^c   Izzo, Joseph ^d   Oparil, Suzanne ^e   Pitt, Bertram ^f   Thomas, James D ^g   Zile, Michael R ^h   Aurigemma, Gerard P ⁱ   Solomon, Scott D ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^c NOVARTIS PHARMA AG   (Switzerland)

^d UNIVERSITY AT BUFFALO   (United States)

^e UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MICHIGAN   (United States)

^g LERNER RESEARCH INSTITUTE   (United States)

^h MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

ⁱ UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

albuminuria; echocardiography; glomerular filtration rate; hypertension

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ALBUMINURIA; ARTERIAL STIFFNESS; ARTICLE; CREATININE BLOOD LEVEL; DIASTOLE; DIASTOLIC DYSFUNCTION; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE WALL; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

EID: 80051919307     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32834a4d38     Document Type: Article

References (44)

1. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 2005; 112:e154-e235.
2. Hillege HL, Fidle V, Diercks GFH, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002; 106:1777-1782.
3. Wachtell K, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE, et al. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med 2003; 139:901-906.
4. Gerstein HC, Mann JFE, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAmMedAssoc 2001; 286:421-426. (Pubitemid 32681484)
5. Solomon SD, Lin J, Solomon CG, Jablonski KA, Rice MM, Steffes M, et al. Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease. Circulation 2007; 116:2687-2693. (Pubitemid 350301148)
6. Jose P, Tomson C, Skali H, Rouleau J, Braunwald E, Arnold JM, et al. Influence of proteinuria on cardiovascular risk and response to angiotensinconverting enzyme inhibition after myocardial infarction. J Am Coll Cardiol 2006; 47:1725-1727.
7. Jackson CE, Solomon SD, Gerstein HC, Zetterstrand S, Olofsson B, Michelson EL, et al. Albuminuria in chronic heart failure: prevalence and prognostic importance. Lancet 2009; 374:543-550.
8. Shulman NB, Ford CE, Hall WD, Blaufox MD, Simon D, Langford HG, Schneider KA. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function: results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 1989; 13:I80-93.
9. Solomon SD, Rice MM, Jablonski KA, Jose P, Domanski M, Sabatine M, et al. Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial. Circulation 2006; 114:26-31. (Pubitemid 44305271)
10. Mann JFE, Gerstein HC, Pogue J, Bosch J, Yusuf. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 2001; 134:629-636. (Pubitemid 32322240)
11. Tokmakova MP, Skali H, Kenchaiah SK, Braunwald E, Rouleau JL, Packer M, et al. Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival and Ventricular Englargement (SAVE) study. Circulation 2004; 110:3667-3673. (Pubitemid 39665255)
12. Anavekar NS, McMurray JJV, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351:1285-1295. (Pubitemid 39258422)
13. Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJV, Yusuf S, et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 2006; 113:671-678.
14. Wachtell K, Palmieri V, Olsen MH, Bella JN, Aalto T, Dahlof B, et al. Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the Losartan Intervention for Endpoint reduction (LIFE) study. Am Heart J 2002; 143:319-326.
15. Leoncini G, Sacchi G, Ravera M, Viazzi F, Ratto E, Vettoretti S, et al. Microalbuminuria is an integrated marker of subclinical organ damage in primary hypertension. J Human Hypertens 2002; 16:399-404. (Pubitemid 34685587)
16. Tsioufis C, Stefanadis C, Toutouza M, Kallikazaros I, Toutouzas K, Tousoulis D, et al. Microalbuminuria is associated with unfavorable cardiac geometric adaptations in essential hypertensive subjects. J Human Hypertens 2002; 16:249-254. (Pubitemid 34441160)
17. Leib W, Mayer B, Stritzke J, Doering A, Hense H-W, Loewel H, et al. Association of low-grade urinary albumin excretion with left ventricular hypertrophy in the general population: the MONICA/KORA Augsburg echocardiographic substudy. Nephrol Dial Transplant 2006; 21:2780-2787. (Pubitemid 44542231)
18. Afshinnia F, Spitalewitz S, Chou S-Y, Gunsburg DZ, Chadow HL. Left ventricular geometry and renal function in hypertensive patients with diastolic heart failure. Am J Kidney Dis 2007; 49:227-236. (Pubitemid 46178396)
19. Moran A, Katz R, Jenny NS, Astor B, Bluemke DA, Lima JA, et al. Left ventricular hypertrophy in mild and moderate reduction in kidney function determined using cardiac magnetic resonance imaging and cystatin C: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis 2008; 52:839-848.
20. Hermans MM, Henry R, Dekker JM, Kooman JP, Kostense PJ, Nijpels G, et al. Estimated glomerular filtration rate and urinary albumin excretion are independently associated with greater arterial stiffness: the Hoorn Study. J Am Soc Nephrol 2007; 18:1942-1952. (Pubitemid 46870332)
21. Upadhyay A, Hwang SJ, Mitchell GF, Vasan RS, Vita JA, Stantchev PI, et al. Arterial stiffness in mild-to-moderate CKD. J Am Soc Nephrol 2009; 20:2044-2053.
22. Starling MR. Left ventricular-arterial coupling relations in the normal human heart. Am Heart J 1993; 125:1659-1666. (Pubitemid 23169481)
23. Kass DA. Ventricular arterial stiffening: integrating the pathophysiology. Hypertension 2005; 46:185-193. (Pubitemid 40946512)
24. Saba PS, Ganau A, Devereux RB, Pini R, Pickering TG, Roman MJ. Impact of arterial elastance as a measure of vascular load on left ventricular geometry in hypertension. J Hypertens 1999; 17:1007-1015. (Pubitemid 29322190)
25. Borlaug BA, Lam CSP, Roger VL, Rodeheffer RJ, Redfield MM. Contractility and ventricular systolic stiffening in hypertensive heart disease: insights into the pathogenesis of heart failure with preserved ejection fraction. J Am Coll Cardiol 2009; 54:410-418.
26. Solomon SD, Janardhanan R, Verma A, Bourgoun M, Daley WL, Purkayastha D, et al. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomized trial. Lancet 2007; 369:2079-2087. (Pubitemid 46935945)
27. Solomon SD, Verma A, Desai A, Hassanein A, Izzo J, Oparil S, et al. Effect of intensive versus standard blood pressure lowering on diastolic function in patients with uncontrolled hypertension and diastolic dysfunction. Hypertension 2010; 55:241-248.
28. Janardhanan R, Daley WL, Naqvi TZ, Mulvagh SL, Aurigemma G, Zile M, et al. Rationale and design: the VALsartan In Diastolic Dysfunction (VALIDD) trial: evolving the management of diastolic dysfunction in hypertension. Am Heart J 2006; 152:246-252. (Pubitemid 44093403)
29. Hassanein A, Desai A, Verma A, Oparil S, Izzo J, Rocha R, et al. EXCEED: Exforge1-intensive control of hypertension to evaluate efficacy in diastolic dysfunction: study rationale, design, and participant characteristics. Ther Adv Cardiovasc Dis 2009; 3:429-439.
30. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new predication equation. Ann Intern Med 1999; 130:461-470. (Pubitemid 29135798)
31. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al., Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18:1440-1463. (Pubitemid 41821197)
32. Kelley RP, Ting CT, Yang TM, Liu CP, Maughan WL, Chang MS, Kass DA. Effective arterial elastance as index of arterial vascular load in humans. Circulation 1992; 86:513-521.
33. Chen C-H, Fetics B, Nevo E, Rochitte CE, Chiou KR, Ding PA, et al. Noninvasive single-beat determination of left ventricular end-systolic elastance in humans. J Am Coll Cardiol 2001; 38:2028-2034. (Pubitemid 33116581)
34. Levey AS, Cattran D, Friedman A, Miller WG, Sedor J, Tuttle K, et al. Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis 2009; 54:205-226.
35. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al. Heart disease and stroke statistics: 2011 update: a report from the American Heart Association. Circulation 2010. [Epub ahead of print]
36. Pontremoli R, Ravera M, Bezante GP, Viazzi F, Nicolella C, Berruti V, et al. Left ventricular geometry and function in patients with essential hypertension and microalbuminuria. J Hypertens 1999; 17:993-1000. (Pubitemid 29322188)
37. Kramer H, Jacobs DR, Bild D, Post W, Saad MF, Detrano R, et al. Urine albumin excretion and subclinical cardiovascular disease. Hypertension 2005; 46:38-43.
38. De Zeeuw D, Parving H-H, Henning RH. Microalbuminuria as an early marker for cardiovascular disease. J Am Soc Nephrol 2006; 17:2100-2105. (Pubitemid 44141898)
39. Tsioufis CP, Lambrou SG, Stefanadis CI, Antoniadis DI, Kallikazaros IE, Pitsavos CE, Toutouzas PK. Microalbuminuria is associated with abnormal thoracic aortic mechanics in essential hypertension. Am J Cardiol 2000; 86:797-801.
40. Jensen JS. Renal and systemic transvascular albumin leakage in severe atheroscelosis. Aterioscler Thromb Vasc Biol 1995; 15:1324-1329.
41. Pedrinelli R, Dell'Omo G, Penno G, Mariani M. Nondiabetic microalbuminuria, endothelial dysfunction and cardiovascular disease. Vasc Med 2001; 6:257-264. (Pubitemid 34256767)
42. Stehouwer CDA, Smulders YM. Microalbuminuria and risk for cardiovascular disease: analysis of potential mechanisms. J Am Soc Nephrol 2006; 17:2106-2111. (Pubitemid 44141899)
43. Stevens LA, Coresh J, Feldman HI, Greene T, Lash JP, Nelson RG, et al. Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol 2007; 18:2749-2757. (Pubitemid 47531202)
44. Levey AS, Stevens LA, Schmid CH, Zhang Y, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150:604-612.